The Latest in Rheumatology News

First Hike of Medicare Funding for Residencies in 25 Years Aims to Help Shortages

September 27, 2024

Business of Medicine

Direct-to-Consumer Testing’s Expansion to Rheumatology Has Benefits but Potential Risks

September 27, 2024

How the Future of Medicine Will Revolve Around Our Gut

September 26, 2024

Doing the Best They Can

September 26, 2024

Business of Medicine

FDA’s Stricter Regulation of Lab-Developed Tests Faces Lawsuits and Lingering Concerns

September 24, 2024

Business of Medicine

Bimekizumab Gains FDA Approval for Psoriatic Arthritis, Axial Spondyloarthritis

September 24, 2024

Muscle Relaxants for Chronic Pain: Where Is the Greatest Evidence?

September 23, 2024

Pain

Patient Navigators in Rheumatology Set to Expand in Importance, Scope With New Medicare Codes

September 23, 2024

Trial Looks at Early Use of Mycophenolate to Reduce Flares, Nephritis

September 23, 2024

Lupus & Connective Tissue Diseases

Hypnosis May Offer Relief During Sharp Debridement of Skin Ulcers

September 23, 2024

Treating Family: Ethicist Discusses Whether It’s Appropriate

September 23, 2024

Business of Medicine

Identifying Drug-Induced Rashes in Skin of Color: Heightened Awareness Can Accelerate Diagnosis

September 23, 2024

Diversity in Medicine

FDA Initiative Aims to Improve Diversity in Clinical Trials

September 23, 2024

Diversity in Medicine

Are You Using the Correct Medication or a Look-Alike?

September 20, 2024

Business of Medicine

Should There Be a Mandatory Retirement Age for Physicians?

September 19, 2024

Business of Medicine